Literature DB >> 8986209

Decreases in dopamine receptors but not in dopamine transporters in alcoholics.

N D Volkow1, G J Wang, J S Fowler, J Logan, R Hitzemann, Y S Ding, N Pappas, C Shea, K Piscani.   

Abstract

It has been hypothesized that ethanol's actions on the dopamine (DA) system may participate in addiction. The purpose of this study was to evaluate the DA system in the brain of alcoholics. We evaluated 10 alcoholics and 17 nonalcoholics using positron emission tomography and [11C]raclopride to measure DA D2 receptors. In addition, in 5 of the alcoholics and 16 of the nonalcoholics, we also measured DA transporters with [11C]d-threo methylphenidate. The ratio of the distribution volumes in striatum to that in cerebellum, which corresponds to Bmax/Kd + 1, was used as model parameter of DA D2 receptor and transporter availability. Dopamine D2 receptor availability (Bmax/Kd) was significantly lower in alcoholics (2.1 +/- 0.5) than in nonalcoholics (2.7 +/- 0.6) (p < 0.05) and was not correlated with days since last alcohol use. Alcoholics showed DA transporter values similar to those in nonalcoholics. The ratio of DA D2 receptor to transporter availability was significantly higher in nonalcoholics (1.4 +/- 0.1) than in alcoholics (1.1 +/- 0.1) (p < 0.005). Alcoholics showed significant reductions in D2 receptors (postsynaptic marker) but not in DA transporter availability (presynaptic marker) when compared with nonalcoholics. Because D2 receptors in striatum are mainly localized in gamma-aminobutyric acid (GABA) cells these results provide evidence of GABAergic involvement in the dopaminergic abnormalities seen in alcoholics.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8986209     DOI: 10.1111/j.1530-0277.1996.tb05936.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  177 in total

1.  Dopamine receptor imaging in alcohol dependency: should personality traits be taken into account?

Authors:  I Goethals; C Van De Wiele; K Audenaert
Journal:  Eur J Nucl Med       Date:  2001-11

2.  Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics.

Authors:  Terry Ritchie; Ernest P Noble
Journal:  Neurochem Res       Date:  2003-01       Impact factor: 3.996

Review 3.  Cognitive and neurobiological mechanisms of alcohol-related aggression.

Authors:  Adrienne J Heinz; Anne Beck; Andreas Meyer-Lindenberg; Philipp Sterzer; Andreas Heinz
Journal:  Nat Rev Neurosci       Date:  2011-06-02       Impact factor: 34.870

Review 4.  Addiction and the brain: the role of neurotransmitters in the cause and treatment of drug dependence.

Authors:  D M Tomkins; E M Sellers
Journal:  CMAJ       Date:  2001-03-20       Impact factor: 8.262

Review 5.  Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex.

Authors:  Rita Z Goldstein; Nora D Volkow
Journal:  Am J Psychiatry       Date:  2002-10       Impact factor: 18.112

Review 6.  Neuroimaging in drug abuse.

Authors:  Kimberly P Lindsey; S John Gatley; Nora D Volkow
Journal:  Curr Psychiatry Rep       Date:  2003-10       Impact factor: 5.285

Review 7.  [Neuroimaging in substance abuse disorders].

Authors:  A de Mendelssohn; S Kasper; J Tauscher
Journal:  Nervenarzt       Date:  2004-07       Impact factor: 1.214

8.  Genetic influences of dopamine transport gene on alcohol dependence: a pooled analysis of 13 studies with 2483 cases and 1753 controls.

Authors:  Mingqing Xu; Zhicheng Lin
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-11-13       Impact factor: 5.067

9.  Alcohol Activates Scabrous-Notch to Influence Associated Memories.

Authors:  Emily Petruccelli; Michael Feyder; Nicolas Ledru; Yanabah Jaques; Edward Anderson; Karla R Kaun
Journal:  Neuron       Date:  2018-10-25       Impact factor: 17.173

Review 10.  Chronic stress, drug use, and vulnerability to addiction.

Authors:  Rajita Sinha
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.